GenSearch to Attend the Presentation of the Panorama France HealthTech 2026

GenSearch is pleased to announce that  Stéphanie Blanc, Sébastien Stoitzner and Pauline Rambaud will take part in the upcoming presentation of the Panorama France HealthTech 2026, organised by France Biotech. The event will take place on 19 February 2026, bringing together leaders, innovators and stakeholders shaping the future of the French and European HealthTech ecosystem.

Read more “GenSearch to Attend the Presentation of the Panorama France HealthTech 2026”

𝗙𝗿𝗼𝗺 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗽𝗲𝗼𝗽𝗹𝗲 – 𝗿𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝗕𝗮𝘀𝗲𝗹

At GenSearch, we were proud to co-host the recent HealthTech Dinner in Basel alongside PwC Switzerland. This invitation-only event brought together senior leaders from across the pharma, biotech, and life sciences sectors. The aim was to explore how the industry is transitioning from product-led models to patient- and consumer-centric ecosystems.
Read more “𝗙𝗿𝗼𝗺 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗽𝗲𝗼𝗽𝗹𝗲 – 𝗿𝗲𝗳𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗳𝗿𝗼𝗺 𝗕𝗮𝘀𝗲𝗹”

We’re Attending HTID 2025 in Paris | GenSearch

Sebastien Stoitzner and Pauline Rambaud will attend the HealthTech Innovation Days (HTID) taking place on 7-8 October 2025 in Paris, France.

Read more “We’re Attending HTID 2025 in Paris | GenSearch”

Is ESG Already Central to Healthtech Strategy?

Is ESG Already Central to Healthtech Strategy?
Our GenSearch’s roundtable, “ESG, déjà au cœur de la stratégie des Healthtech?”, perfectly aligned with our commitment to share market topics expertise within our network and to promoting sustainable practices across the life sciences, biotech, and Healthtech sectors..

Read more “Is ESG Already Central to Healthtech Strategy?”

Unlocking Private Equity: What It Really Takes to Lead in a PE-Backed Company

In this session, our expert speakers shared insights into the realities of leadership in private equity-backed companies, what demands, what often goes unsaid, and how to thrive in this high-performance environment.
  Read more “Unlocking Private Equity: What It Really Takes to Lead in a PE-Backed Company”